SuperiorMed Holdings Limited
Definitive (DA signed)Health Care · healthcare services
- What it is
- A private company in health care preparing to list via a SPAC merger. Full profile in progress.
- What it’s doing now
- Merging with STARRY SEA ACQUISITION CORP (SSEA) — definitive (da signed), announced Aug 26, 2026.
- What you should know
- Data is still being assembled for this company — what is shown below is everything we have verified so far.
What the company says about itself
Web research — not auditedSuperiorMed is a longevity-focused medical organization offering precision medicine, regenerative therapies, and personalized health optimization. It operates clinics in Dubai, including a Longevity Clinic & Spa at JW Marriott Dubai Marina and a Longevity Clinic at The Retreat Palm Jumeirah, providing services such as advanced diagnostics, metabolic optimization, and luxury wellness retreats.
- Markets:
- Healthcare | Longevity Medicine | Regenerative Therapies | Medical Tourism
- Products:
- Longevity Program | Personalized Longevity Medicine | Advanced Diagnostics | Regenerative Longevity Therapies | Metabolic & Hormone Optimization | Recovery & Performance Therapies | Bespoke Longevity Retreats | Elite Medical Concierge Services
[WEB-INTEL 2026-08-26] 2 finding(s) · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "SuperiorMed Holdings Limited Announces Entering into an Agreement and Plan of Merger with Starry Sea Acquisition Corp on August 22, 2026" [https://www.globenewswire.com/news-release/2026/08/22/3349373/0/en/superiormed-holdings-limited-announces-entering-into-an-agreement-and-plan-of-merger-with-starry-sea-acquisition-corp.html] · web source asserts a FILING-ONLY figure (deadline / trust / status / floor / price) and it was NOT stored: "The ordinary shares held by certain SuperiorMed shareholders will be subject to lock-up agreements for a period of 180 days following the closing of the Transaction" [https://www.globenewswire.com/news-release/2026/08/22/3349373/0/en/superiormed-holdings-limited-announces-entering-into-an-agreement-and-plan-of-merger-with-starry-sea-acquisition-corp.html]
Source: https://superiormed.ae/ · captured Aug 26, 2026 · marketing claims are reported as claims, never merged into the filed figures above.
The deal it’s entering
SuperiorMed Holdings Limited is merging with STARRY SEA ACQUISITION CORP (SSEA), a $58M SPAC currently marked Deal announced and trading at $10.31 against $10.00 in trust per share.
| Headline equity value | $200M |
How to read these numbers: headline vs effective valuation · what a definitive agreement commits
What exactly is being valued, and at what
Was this deal done at an expensive or a cheap valuation?
SpacBrain’s read on the price
No multiple can be computed
We hold no revenue figure in US dollars for SuperiorMed Holdings Limited, so there is nothing to divide the price by and no multiple can be struck. It is not recorded as pre-revenue either — this is a gap in our record, not a finding that the company has no sales. The deal values it at $200M regardless.
We have not extracted a revenue figure for this company from its filings yet. That is our gap, not a statement about the business.
Announced equity value (net debt unknown).
Not extracted from the filings yet.
Not computable — no revenue figure has been extracted from the filings yet.
No listed comparable carries a revenue multiple we can use.
What qualifies the figures above
- The target's cash and debt are not in the filings we have, so this is an equity value used as a stand-in for enterprise value.
Common questions
Is SuperiorMed Holdings Limited going public?
SuperiorMed Holdings Limited has a signed merger with the SPAC STARRY SEA ACQUISITION CORP (SSEA), announced Aug 26, 2026. Deal status: Definitive (DA signed).
What is SuperiorMed Holdings Limited's SPAC deal valuation?
The announced headline equity value is $200M.
Was SuperiorMed Holdings Limited bought at an expensive or a cheap valuation?
We hold no revenue figure in US dollars for SuperiorMed Holdings Limited, so there is nothing to divide the price by and no multiple can be struck. It is not recorded as pre-revenue either — this is a gap in our record, not a finding that the company has no sales. The deal values it at $200M regardless.
Does SuperiorMed Holdings Limited have revenue?
The filings we've parsed don't state a usable revenue figure yet; this profile is updated as new documents land.
Educational content, not investment advice.
- Oak Hill Bio — with RACC ($160M) · pre-revenue
- Longevity Biomedical — with FTII ($100M) · pre-revenue
- GNQ Insilico — with IBAC ($500M)
- HCC Healthcare Pte. — with RFAM ($500M)
- OmniAb — with AHPA
- Jasper Therapeutics — with AMHC